A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling

BACKGROUND: Breast cancer exhibits poor prognosis and high relapse rates following chemotherapy therapeutics. Thus, this study aims to develop effective novel agents regulating the core molecular pathway of breast cancer such as Wnt/β-catenin signaling. METHODS: The present study screened a novel in...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Liu-Jun, Yang, Dong-Lin, Chen, He-Ying, Huang, Jiu-Hong, Zhang, Ya-Jun, Qin, Hong-Xia, Wang, Juan-Li, Tang, Dian-Yong, Chen, Zhong-Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553630/
https://www.ncbi.nlm.nih.gov/pubmed/33116593
http://dx.doi.org/10.2147/OTT.S266752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553630/
https://www.ncbi.nlm.nih.gov/pubmed/33116593
http://dx.doi.org/10.2147/OTT.S266752

Ejemplares similares